Abstract
UNLABELLED: A young man with daily nipple discharge was told to wait and see. After 18 months, at 32, he developed a subareolar lump which proved to be invasive ductal carcinoma. There were no epidemiological or genetic risk factors, no mutations in BRCA 1 + 2. Male breast cancer (MBC) patients have a lower survival rate than females due to a delay in diagnosis. Greater focus on MBC is necessary in order to change this.
TREATMENT: We chose to follow the guidelines for young women. Some studies imply that early MBC is more benign but there are no randomised trials on treatment.
| Bidragets oversatte titel | Breast cancer in 32-year-old male |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 170 |
| Udgave nummer | 19 |
| Sider (fra-til) | 1663 |
| ISSN | 0041-5782 |
| Status | Udgivet - 5 maj 2008 |
| Udgivet eksternt | Ja |
Emneord
- Adult
- Breast Neoplasms, Male/diagnosis
- Carcinoma, Ductal, Breast/diagnosis
- Humans
- Male
- Nipples/metabolism
- Prognosis